The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Innate immunity and intestinal microbiota in the development of Type 1 diabetes
Open accessAbstract
Type 1 diabetes (T1D) is a debilitating autoimmune disease that results from T-cell-mediated destruction of insulin-producing beta-cells. Its incidence has increased during the past several decades in developed countries, suggesting that changes in the environment (including the human microbial environment) may influence disease pathogenesis. The incidence of spontaneous T1D in non-obese diabetic (NOD) mice can be affected by the microbial environment in the animal housing facility or by exposure to microbial stimuli, such as injection with mycobacteria or various microbial products. Here we show that specific pathogen-free NOD mice lacking MyD88 protein (an adaptor for multiple innate immune receptors that recognize microbial stimuli) do not develop T1D. The effect is dependent on commensal microbes because germ-free MyD88-negative NOD mice develop robust diabetes, whereas colonization of these germ-free MyD88-negative NOD mice with a defined microbial consortium (representing bacterial phyla normally present in human gut) attenuates T1D. We also find that MyD88 deficiency changes the composition of the distal gut microbiota, and that exposure to the microbiota of specific pathogen-free MyD88-negative NOD donors attenuates T1D in germ-free NOD recipients. Together, these findings indicate that interaction of the intestinal microbes with the innate immune system is a critical epigenetic factor modifying T1D predisposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice deficient in MyD88 display an altered microbiota composition.56”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [56]
In the citing paper
“TLR5 is of particular importance in shaping the gut microbiota,53–56 which might be confined to a critical time window during neonatal life.40”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [56]
In the citing paper
“GF non-obese diabetic mice lacking MyD88 signaling robustly develop T1D”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [56]
In the citing paper
“while microbial colonization of these mice attenuates the disease.56”
From Interaction between microbiota and immunity in health and disease (2020) · cites this paper as [56]
In the citing paper
“Changes in the proportions of specific taxa of gut microbiota have been observed in various disease states, including obesity68,69, inflammatory bowel disease70, type 1 and type 2 diabetes mellitus71,72, biliary disease73, and intestinal cancers74,75 among many others.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [71]
In the citing paper
“there is evidence that particular population changes are associated with pathologies that confer an increased risk of developing PH and other vascular disease, including obesity[273–275], diabetes[276], and insulin resistance[277].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [276]
In the citing paper
“Elevations in the Firmicutes:Bacteroidetes ratio have been associated with a high-fat diet and obesity[274,328,329], irritable bowel syndrome[330], hypertension[331], type 1 diabetes[276], and HIV[332].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [276]
In the citing paper
“The Muc2-KO mouse possesses a distinct gut-associated bacterial community that is influenced by its altered genetic and immune states, as has been shown in other genetic knockout mouse models.4,53–55”
From Using Corticosteroids to Reshape the Gut Microbiome: Implications for Inflammatory Bowel Diseases (2015) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naive Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 20,145
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Self-citationPathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
16S ribosomal DNA amplification for phylogenetic study
Weisburg, W. G., Barns, S. M., Pelletier, D. A., & Lane, D. J. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.2.697-703.1991 · Cited by 11,970
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Self-citationUniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
ARB: a software environment for sequence data
Ludwig, W. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh293 · Cited by 6,714
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Self-citationRecognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Approaching the asymptote? Evolution and revolution in immunology.Preprint
Janeway, C. (1989) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.1989.054.01.003 · Cited by 3,396
Flagged first, then by citations
Research works printed but not linked: 1
- Funda, D. P., Fundova, P. & Harrison, L. C. Microflora-dependency of selected diabetes-preventive diets: germ-free and ex-germ-free monocolonized NOD mice as models for studying environmental factors in type 1 diabetes. Proc. 13th Int. Congr. Immunol. MS-11.4 16 (Brazilian Society for Immunology, Rio de Janeiro, 2007)
Cited by
Sorted by citations
Items 801–900 of 1,002
Strzępa, A., Majewska‐Szczepanik, M., Lobo, F. M., Li, W., & Szczepanik, M. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.11.052 · Cited by 55
Gancao-Gansui combination impacts gut microbiota diversity and related metabolic functions
Yu, J., Guo, J., Tao, W., Liu, P., Shang, E., Zhu, Z., Fan, X., Shen, J., Hua, Y., Zhu, K. Y., et al. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.11.031 · Cited by 53
Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation
Cheru, L., Saylor, C. F., & Lo, J. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00332-6 · Cited by 53
Intestinal Microbes in Autoimmune and Inflammatory Disease
Wu, W.-J. H., Zegarra-Ruiz, D. F., & Diehl, G. E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.597966 · Cited by 54
Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies
Leal‐Lopes, C., Velloso, F. J., Campopiano, J. C., Sogayar, M. C., & Correa, R. G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/284680 · Cited by 54
Autoimmunity and the pathogenesis of type 1 diabetes
Csorba, T. R., Lyon, A. W., & Hollenberg, M. D. (2010) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408361003787171 · Cited by 54
Ho, J., Reimer, R. A., Doulla, M., & Huang, C. (2016) · Trials · doi:10.1186/s13063-016-1486-y · Cited by 52
Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?
Das, U. N. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00182 · Cited by 53
Dietary Cows’ Milk Protein A1 Beta-Casein Increases the Incidence of T1D in NOD Mice
Chia, J. S., McRae, J. L., Enjapoori, A. K., Lefèvre, C. M., Kukuljan, S., & Dwyer, K. M. (2018) · Nutrients · doi:10.3390/nu10091291 · Cited by 52
Zheng, P., Li, Y., Wu, J., Zhang, H., Huang, Y., Tan, X., Pan, J., Duan, J., Liang, W., Yin, B., et al. (2020) · Advanced Science · doi:10.1002/advs.202001296 · Cited by 52
Fernández-Edreira, D., Liñares-Blanco, J., & Fernandez-Lozano, C. (2021) · Expert Systems with Applications · doi:10.1016/j.eswa.2021.115648 · Cited by 53
Gut microbiota and metabolites in the pathogenesis of endocrine disease
Fenneman, A. C., Rampanelli, E., Yin, Y. S., Ames, J., Blaser, M. J., Fliers, E., & Nieuwdorp, M. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190686 · Cited by 51
Chicory: Understanding the Effects and Effectors of This Functional Food
Pouille, C. L., Ouaza, S., Roels, E., Behra-Miellet, J., Tourret, M., Molinié, R., Fontaine, J., Mathiron, D., Gagneul, D., Taminiau, B., et al. (2022) · Nutrients · doi:10.3390/nu14050957 · Cited by 51
Tian, Z., Yu, Y., Fang, H., Xie, W., & Guo, M. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac634 · Cited by 51
The Effects of Age and Cx 3 cr1 Deficiency on Retinal Microglia in the Ins2 Akita Diabetic Mouse
Kezic, J. M., Chen, X., Rakoczy, E. P., & McMenamin, P. G. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10876 · Cited by 53
An Analysis of the Role of the Indigenous Microbiota in Cholesterol Gallstone Pathogenesis
Fremont, J. J., Ge, Z., Umana, C. R., Whary, M. T., Taylor, N. S., Muthupalani, S., Carey, M. C., Fox, J. G., & Maurer, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070657 · Cited by 51
Of genes and microbes: solving the intricacies in host genomes
Wang, J., Chen, L., Zhao, N., Xu, X., Xu, Y., & Zhu, B. (2018) · Protein & Cell · doi:10.1007/s13238-018-0532-9 · Cited by 51
Sheng, Y., Zheng, S., Zhang, C., Zhao, C., He, X., Xu, W., & Huang, K. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.040 · Cited by 51
Influence of Porphyromonas gingivalis in gut microbiota of streptozotocin‐induced diabetic mice
Ohtsu, A., Takeuchi, Y., Katagiri, S., Suda, W., Maekawa, S., Shiba, T., Komazaki, R., Udagawa, S., Sasaki, N., Hattori, M., et al. (2019) · Oral Diseases · doi:10.1111/odi.13044 · Cited by 52
Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity
Honkanen, J. K., Vuorela, A., Muthas, D., Orivuori, L., Luopajärvi, K., Tejesvi, M. V., Lavrinienko, A., Pirttilä, A. M., Fogarty, C. L., Härkönen, T., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00468 · Cited by 51
Gut microbiota and type 1 diabetes: a two-sample bidirectional Mendelian randomization study
Luo, M., Sun, M., Wang, T., Zhang, S., Song, X., Liu, X., Wei, J., Chen, Q., Zhong, T., & Qin, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1163898 · Cited by 52
Autoimmunity's next top models
Wekerle, H., Flügel, A., Fugger, L. H., Schett, G. A., & SERREZE, D. V. (2012) · Nature Medicine · doi:10.1038/nm.2635 · Cited by 53
Predominant Effect of Host Genetics on Levels of Lactobacillus johnsonii Bacteria in the Mouse Gut
Buhnik‐Rosenblau, K., Danin‐Poleg, Y., & Kashi, Y. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.00324-11 · Cited by 53
Antibiotics, gut microbiota, environment in early life and type 1 diabetes
Hu, Y., Wong, F. S., & Li, W. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.034 · Cited by 50
Self-citationNeedell, J. C., Ir, D., Robertson, C. E., Kroehl, M., Frank, D. N., & Zipris, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183786 · Cited by 51
Miller, K., Vicentini, F., Hirota, S. A., Sharkey, K. A., & Wieser, M. E. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814047116 · Cited by 50
Long, Y., & Luo, J. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3066-0 · Cited by 50
Receptors Mediating Host-Microbiota Communication in the Metaorganism: The Invertebrate Perspective
Dierking, K., & Pita, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01251 · Cited by 57
García-López, R., Vázquez-Castellanos, J. F., & Moyá, A. (2015) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2015.00141 · Cited by 49
Unanue, E. R., Ferris, S. T., & Carrero, J. A. (2016) · Immunological Reviews · doi:10.1111/imr.12430 · Cited by 49
Gut Microbiota Drives Metabolic Disease in Immunologically Altered Mice
Chassaing, B., Aitken, J. D., Gewirtz, A. T., & Vijay–Kumar, M. (2012) · Advances in immunology · doi:10.1016/b978-0-12-394300-2.00003-x · Cited by 51
TLR2: A Crossroads between Infections and Autoimmunity?
Borrello, S., Nicolò, C., Delogu, G., Pandolfi, F., & Ria, F. (2011) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201102400301 · Cited by 49
Microbial sensing in the intestine
Wan, T., Wang, Y., He, K., & Zhu, S. (2023) · Protein & Cell · doi:10.1093/procel/pwad028 · Cited by 50
Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma
Neto, A. G., Whitaker, A., & Pei, Z. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.005 · Cited by 48
Merrifield, C. A., Lewis, M. C., Berger, B. W., Cloarec, O., Heinzmann, S. S., Charton, F., Krause, L., Levin, N. S., Duncker, S. C., Mercenier, A., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2015.90 · Cited by 50
Aw, W., & Fukuda, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0456-2 · Cited by 48
Arrazuria, R., Elguezábal, N., Juste, R. A., Derakhshani, H., & Khafipour, E. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00446 · Cited by 48
The Role of the Human Microbiome in Chemical Toxicity
Koontz, J. M., Dancy, B. C. R., Horton, C. L., Stallings, J. D., DiVito, V. T., & Lewis, J. A. (2019) · International Journal of Toxicology · doi:10.1177/1091581819849833 · Cited by 48
Gianchecchi, E., & Fierabracci, A. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.07.006 · Cited by 50
Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD
Briskey, D., Tucker, P. S., Johnson, D. W., & Coombes, J. S. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.05.002 · Cited by 47
Ding, P., Tan, Q., Wei, Z., Chen, Q., Wang, C., Qi, L., Wen, L., Zhang, C., & Yao, C. (2022) · Bone Research · doi:10.1038/s41413-022-00210-3 · Cited by 47
Chen, Q., Wang, Y., Jiao, F., Shi, C., Pei, M., Wang, L., & Gong, Z. (2020) · Scientific Reports · doi:10.1038/s41598-020-78935-6 · Cited by 48
Siddiqui, N. Z., Rehman, A. U., Yousuf, W., Khan, A. I., Farooqui, N. A., Zang, S., Xin, Y., & Wang, L. (2022) · Gut Pathogens · doi:10.1186/s13099-022-00512-1 · Cited by 47
Mechanism of Iron Ion Homeostasis in Intestinal Immunity and Gut Microbiota Remodeling
Bao, H., Wang, Y., Xiong, H., Xia, Y., Cui, Z., & Liu, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020727 · Cited by 48
Tran, C. D., Grice, D. M., Wade, B., Kerr, C. A., Bauer, D. C., Li, D., & Hannan, G. N. (2015) · Future Microbiology · doi:10.2217/fmb.15.54 · Cited by 48
Neil, J. A., & Coulson, B. S. (2015) · Diabetologia · doi:10.1007/s00125-015-3562-3 · Cited by 50
Alkanani, A. K., Hara, N., Lien, E., Ir, D., Kotter, C. V., Robertson, C. E., Wagner, B. D., Frank, D. N., & Zipris, D. (2013) · Diabetes · doi:10.2337/db13-1007 · Cited by 48
Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases
Opdenakker, G., Proost, P., & Damme, J. V. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.07.002 · Cited by 48
Brooks, P., Brakel, K. A., Bell, J. A., Bejcek, C. E., Gilpin, T. E., Brudvig, J. M., & Mansfield, L. S. (2017) · Microbiome · doi:10.1186/s40168-017-0284-4 · Cited by 47
Pancreas–Microbiota Cross Talk in Health and Disease
Adolph, T. E., Mayr, L., Grabherr, F., Schwärzler, J., & Tilg, H. (2019) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082018-124306 · Cited by 48
del Campo, C. M. Z.-M., Rosas, M., & Guarner‐Lans, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041224 · Cited by 46
Innate immunity and the pathogenesis of type 1 diabetes
Grieco, F. A., Vendrame, F., Spagnuolo, I., & Dotta, F. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-010-0206-z · Cited by 46
TLRs, NF- κ B, JNK, and Liver Regeneration
Iimuro, Y., & Fujimoto, J. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/598109 · Cited by 48
Tai, N., Wong, F. S., & Li, W. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300547 · Cited by 46
Self-citationInterpretable and accurate prediction models for metagenomics data
Prifti, E., Chevaleyre, Y., Hanczar, B., Belda, E., Danchin, A., Clément, K., & Zucker, J. (2020) · GigaScience · doi:10.1093/gigascience/giaa010 · Cited by 47
The Microbiota-Gut Axis in Premature Infants: Physio-Pathological Implications
Bresesti, I., Salvatore, S., Valetti, G., Baj, A., Giaroni, C., & Agosti, M. A. (2022) · Cells · doi:10.3390/cells11030379 · Cited by 51
Fratianni, F., Cardinale, F., Russo, I., Iuliano, C., Tremonte, P., Coppola, R., & Nazzaro, F. (2014) · Journal of Microencapsulation · doi:10.3109/02652048.2013.871361 · Cited by 46
Bollyky, P. L., Bice, J. B., Sweet, I. R., Falk, B. A., Gebe, J. A., Clark, A., Gersuk, V. H., Aderem, A. A., Hawn, T. R., & Nepom, G. T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005063 · Cited by 48
Intestinal Microbiota as an Alternative Therapeutic Target for Epilepsy
Wu, J., Zhang, Y., Yang, H., Rao, Y., Miao, J., & Lu, X. (2016) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2016/9032809 · Cited by 46
The complex link and disease between the gut microbiome and the immune system in infants
Zhang, H., Zhang, Z., Liao, Y., Zhang, W., & Tang, D. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.924119 · Cited by 45
Leigh, S.-J., Kaakoush, N. O., Bertoldo, M. J., Westbrook, R. F., & Morris, M. J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0734-9 · Cited by 45
Pathobionts from chemically disrupted gut microbiota induce insulin-dependent diabetes in mice
Yang, X., Wang, Z., Niu, J., Zhai, R., Xue, X., Wu, G. G., Fang, Y., Meng, G., Yuan, H., Zhao, L., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01507-z · Cited by 47
Seal, J. B., Alverdy, J. C., Zaborina, O. Y., & An, G. C. (2011) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-8-33 · Cited by 45
Host-Microbe Interactions in Microgravity: Assessment and Implications
Foster, J. S., Wheeler, R. M., & Pamphile, R. (2014) · Life · doi:10.3390/life4020250 · Cited by 47
Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity
Meng, X. L., Zhou, H., Shen, H., Lufumpa, E., Li, X., Guo, B., & Li, B. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.006 · Cited by 46
Eribo, O. A., du Plessis, N., & Chegou, N. N. (2021) · Infection and Immunity · doi:10.1128/iai.00321-21 · Cited by 45
The role of the immune system in regulating the microbiota
Willing, B. P., Gill, N., & Finlay, B. B. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12520 · Cited by 45
Bélteky, M., Milletich, P. L., Ahrens, A. P., Triplett, E. W., & Ludvigsson, J. (2023) · Diabetologia · doi:10.1007/s00125-023-05895-7 · Cited by 44
Semi-automated extraction of microbial DNA from feces for qPCR and phylogenetic microarray analysis
Nylund, L., Heilig, H. G. H. J., Salminen, S., de Vos, W. M., & Satokari, R. M. (2010) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2010.09.003 · Cited by 44
The gut as a regulator of early inflammation in type 1 diabetes
Vaarala, O. (2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283488218 · Cited by 44
miR-487a-3p upregulated in type 1 diabetes targets CTLA4 and FOXO3
Żurawek, M., Dzikiewicz‐Krawczyk, A., Iżykowska, K., Ziółkowska‐Suchanek, I., Skowrońska, B., Czainska, M., Podralska, M., Fichna, P., Przybylski, G. K., Fichna, M., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.044 · Cited by 45
The Role of Gut Microbiome in Autoimmune Uveitis
Fu, X., Chen, Y., & Chen, D. (2020) · Ophthalmic Research · doi:10.1159/000510212 · Cited by 44
Therapeutic implications of manipulating and mining the microbiota
Shanahan, F. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.174649 · Cited by 45
Zhang, Q., Linke, V., Overmyer, K. A., Traeger, L. L., Kasahara, K., Miller, I. J., Manson, D. E., Polaske, T. J., Kerby, R. L., Kemis, J. H., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01326-w · Cited by 43
You, Y., Xiang, T., Yang, C. H., Xiao, S., Tang, Y., Luo, G., Ling, Z., Luo, F., & Chen, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2545417 · Cited by 45
Tabbaa, M., Golubić, M., Roizen, M. F., & Bernstein, A. (2013) · Nutrients · doi:10.3390/nu5083299 · Cited by 43
Greiner, T. U., Hyötyläinen, T., Knip, M., Bäckhed, F., & Orešič, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110359 · Cited by 44
TLR2 signaling improves immunoregulation to prevent type 1 diabetes
Filippi, C. M., Ehrhardt, K., Estes, E. A., Larsson, P., Oldham, J. E., & von Herrath, M. G. (2011) · European Journal of Immunology · doi:10.1002/eji.200939841 · Cited by 43
Probiotics can really cure an autoimmune disease?
Yousefi, B., Eslami, M., Ghasemian, A., Kokhaei, P., & Sadeghnejhad, A. (2019) · Gene Reports · doi:10.1016/j.genrep.2019.100364 · Cited by 43
Is it true that gut microbiota is considered as panacea in cancer therapy?
Farrokhi, A. S., Darabi, N., Yousefi, B., Askandar, R. H., Shariati, M., & Eslami, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28333 · Cited by 43
Toll-Like Receptors and Type 1 Diabetes
Zipris, D. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_25 · Cited by 43
Wang, X., Luo, Y., He, S., Lu, Y., Gong, Y., Gao, L. P., Mao, S., Liu, X., Jiang, N., Pu, Q., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00572-9 · Cited by 43
García-Gutiérrez, E., O’Mahony, A. K., dos Santos, R. S., Marroquí, L., & Cotter, P. D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2401654 · Cited by 43
The Intestinal Microbiome: Relationship to Type 1 Diabetes
Neu, J., Lorca, G. L., Kingma, S. D. K., & Triplett, E. W. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.008 · Cited by 42
Life on the edge: the balance between macrofauna, microflora and host immunity
Bancroft, A. J., Hayes, K. S., & Grencis, R. K. (2012) · Trends in Parasitology · doi:10.1016/j.pt.2011.12.001 · Cited by 43
Lymphocytes in neuroprotection, cognition and emotion: Is intolerance really the answer?
Rook, G. A. W., Lowry, C. A., & Raison, C. L. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.12.005 · Cited by 44
The microbiota in inflammatory bowel disease: friend, bystander, and sometime-villain
Shanahan, F. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00502.x · Cited by 43
Kovatcheva‐Datchary, P., Tremaroli, V., & Bäckhed, F. (2013) · Springer eBooks · doi:10.1007/978-3-642-30144-5_87 · Cited by 46
Pearson, J. A., Tai, N., Ekanayake‐Alper, D. K., Peng, J., Hu, Y., Hager, K. M., Compton, S. R., Wong, F. S., Smith, P. C., & Li, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02654 · Cited by 42
Self-citationYan, J., Chen, Q., Tian, L., Li, K., Lai, W., Bian, L., Han, J., Jia, R., Liu, X., & Xi, Z. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.153279 · Cited by 42
Gender bias in lupus: does immune response initiated in the gut mucosa have a role?
Gaudreau, M., Johnson, B. M., Gudi, R. R., Gadban, M. M. A., & Vasu, C. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12587 · Cited by 43
Wang, M., Zhang, L., Chang, W., & Zhang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1096551 · Cited by 44
New and future immunomodulatory therapy in type 1 diabetes
Tooley, J., Waldron-Lynch, F., & Herold, K. C. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.01.001 · Cited by 44
Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse
Lee, A., Ghoreishi, M., Cheng, W. K., Chang, T.-Y. E., Zhang, Y. Q., & Dutz, J. P. (2011) · Diabetologia · doi:10.1007/s00125-011-2083-y · Cited by 43
Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus
Tabarrozzi, A. E. B., Castro, C. N., Dewey, R. A., Sogayar, M. C., Labriola, L., & Perone, M. J. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12019 · Cited by 41
Immuno-ecology: how the microbiome regulates tolerance and autoimmunity
Paun, A., & Danska, J. S. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.09.004 · Cited by 43
Pig models on intestinal development and therapeutics
Yin, L., Yang, H., Li, J., Li, Y., Ding, X., Wu, G., & Yin, Y. (2017) · Amino Acids · doi:10.1007/s00726-017-2497-z · Cited by 41
Nutrition, Microbiota and Role of Gut-Brain Axis in Subjects with Phenylketonuria (PKU): A Review
Verduci, E., Carbone, M. T., Borghi, E., Ottaviano, E., Burlina, A., & Biasucci, G. (2020) · Nutrients · doi:10.3390/nu12113319 · Cited by 41
Does the human microbiome tell us something about race?
Delgado, A. N., & Baedke, J. (2021) · Humanities and Social Sciences Communications · doi:10.1057/s41599-021-00772-3 · Cited by 43
Metadata
- Authors
- Wen, L., Ley, R. E., Volchkov, P. Y., Stranges, P. B., Avanesyan, L., Stonebraker, A. C., Hu, C., Wong, F. S., Szot, G. L., Bluestone, J. A., Gordon, J. I., & Chervonsky, A. V.
- Affiliations
- Washington University in St. Louis (US)
- University of Chicago (US)
- Jackson Laboratory (US)
- Yale University (US)
- University of Bristol (GB)
- University of California, San Francisco (US)
- Corresponding author
- Chervonsky, Alexander V.
- ORCID
- Venue
- Nature
- Published
- 2008-09-21
- Volume
- 455
- Issue
- 7216
- Pages
- 1109-1113
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2574766
- OpenAlex
- W2148067809
- Cited by
- 1,921
- References
- 39
- Citations by year
- 2026: 23 · 2025: 49 · 2024: 75 · 2023: 69 · 2022: 105 · 2021: 86 · 2020: 112 · 2019: 137 · 2018: 134 · 2017: 128 · 2016: 141 · 2015: 137 · 2014: 138 · 2013: 119 · 2012: 132
- FWCI
- 62.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R37AI046643)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK030292, DK-30292, DK 45735, DK063452, R21DK063452, DK 70977, DK42086, R01DK070977, P30DK063720, P30DK042086, P30DK056341, R01DK030292, P30DK045735)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, innate immunity, gut microbiota, MyD88, Toll-like receptors, NOD mice, germ-free mice, commensal bacteria, autoimmune disease susceptibility, microbial products, mycobacteria, disease prevention, beta cell destruction, host-microbe interactions
- MeSH terms
- Animals, Bacteria, Diabetes Mellitus, Type 1, Female, Immunity, Innate, Interferon-gamma, Intestines, Islets of Langerhans, Male, Molecular Sequence Data, Phylogeny, Specific Pathogen-Free Organisms, Time Factors, Mice, SCID, Mice, Inbred NOD, Mice, Knockout, CD8-Positive T-Lymphocytes, Mice, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
